Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 12—December 2023
Research

Cost of Acute and Sequelae Care for Japanese Encephalitis Patients, Bangladesh, 2011–2021

Rebeca SultanaComments to Author , Rose Slavkovsky, Md. Redowan Ullah, Zareen Tasnim, Sharmin Sultana, Shifat Khan, Tahmina Shirin, Shamsul Haque, Md. Tanvir Hossen, Md. Monjurul Islam, Jesmin Ara Khanom, Abrarul Haque, Arifa Nazneen, Nadia Ali Rimi, Kamal Hossain, Md. Tanbirul Islam, Shariful Hasan, Md. Shameem Yazdany, Md. Shamim Ahsan, Kamran Mehedi, Anthony A. Marfin, G. William Letson, Clint Pecenka, and An Le Thanh Nguyen
Author affiliations: icddr,b, Dhaka, Bangladesh (R. Sultana, M.R. Ullah, Z. Tasnim, S. Khan, A. Haque, A. Nazneen, N.A. Rimi, K. Hossain); PATH, Seattle, Washington, USA (R. Slavkovsky, A.A. Marfin, G.W. Letson, C. Pecenka); Institute of Epidemiology Diseases Control and Research, Dhaka (S. Sultana, T. Shirin); Maternal, Newborn, Child and Adolescent Health, Dhaka (M.S. Haque, M.T. Hossen, M.M. Islam, J.A. Khanom); World Health Organization, Dhaka (M.T. Islam); Rangpur Medical College Hospital, Rangpur, Bangladesh (S. Hasan); Rajshahi Medical College Hospital, Rajshahi, Bangladesh (M.S. Yazdany); Chattogram Medical College Hospital, Chittagong, Bangladesh (M.S. Ahsan); PATH, Dhaka (K. Mehedi); PATH, Ho Chi Minh City, Vietnam (A.L.T. Nguyen)

Main Article

Table 4

Cost of illness by patient age, sex, illness severity, and wealth index of Japanese encephalitis patients with acute onset, initial sequelae, and long-term sequelae, Bangladesh, November 2011–December 2021*

Categories* Acute, n = 55
 Initial sequelae, n = 65
 Long-term sequelae, n = 90
No. Mean (SE) Median No. Mean (SE) Median No. Mean (SE) Median
Patient age, y
<18 34 898 (90) 883 35 60 (13) 23 36 19 (5) 5
18–30 7 1,177 (231) 1,318 8 54 (20) 34 10 45 (26) 13
31–40 1 1,157 1,157 2 335 (271) 335 7 97 (32) 64
41–50 4 876 (263) 965 4 91 (35) 90 5 148 (62) 194
51–60 4 871 (186) 911 7 128 (45) 75 12 64 (23) 41
>60 5 835 (166) 968 6 31 (12) 23 14 47 (14) 23
p value
 0.810
0.123
0.002
Patient sex
M 30 1,089 (100) 1,076 32 91 (22) 43 55 55 (11) 24
F 25 738 (74) 790 30 59 (14) 33 29 32 (9) 9
p value
 0.011
0.35
0.069
Illness severity
Mild 20 720 (74) 747 11 27 (11) 11 11 9 (3) 8
Moderate 11 937 (96) 1,023 16 57 (13) 31 37 60 (14) 17
Severe 24 1,100 (127) 1,006 35 99 (22) 64 36 46 (10) 29
p value
 0.064
0.038
0.035
Wealth quantile
Poor 11 865 (147) 837 12 84 (18) 85 16 67 (23) 12
Lower middle 12 924 (93) 953 12 90 (90) 22 16 33 (9) 17
Middle 10 982 (242) 709 13 37 (12) 23 18 56 (20) 13
Upper middle 11 1,076 (146) 963 12 75 (20) 74 17 20 (6) 12
Rich 11 804 (135) 968 13 91 (44) 40 17 61 (20) 35
p value 0.742 0.403 0.518

*Costs are in US$. Acute group costs are the total amount, and sequelae group costs are monthly amounts.

Main Article

Page created: November 14, 2023
Page updated: November 18, 2023
Page reviewed: November 18, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external